Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors

Peptides

Volumn 62, Issue , 2014, Pages 164-175

  Sitticharoon, Chantacha ^a   Nway, Nay Chi ^a   Chatree, Saimai ^a   Churintaraphan, Malika ^a   Boonpuan, Peerada ^a   Maikaew, Pailin ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adiponectin; Obesity; Omentin; QUICKI; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; PEPTIDE YY; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INSULIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE EXPRESSION; GENERAL PATHOLOGICAL PARAMETERS; HIP CIRCUMFERENCE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; METABOLISM; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT GAIN; BIOSYNTHESIS; BLOOD; GENE EXPRESSION REGULATION; GENETICS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPONECTIN; ADULT; BODY MASS INDEX; CYTOKINES; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LECTINS; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PEPTIDE YY; SUBCUTANEOUS FAT;

EID: 84908455747     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.10.006     Document Type: Article

References (49)

1. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization technical report series vol. 854 1995 1 452
2. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 January (9403) 2004 157 163
3. Obesity: Situation and Trends 2013 Global Health Observatory (GHO), World Health Organization (WHO)
4. A. Acosta, M.D. Hurtado, O. Gorbatyuk, M. La Sala, D. Duncan, and G. Aslanidi Salivary PYY: a putative bypass to satiety PLoS ONE 6 10 2011 e26137
5. C.R. Balistreri, C. Caruso, and G. Candore The role of adipose tissue and adipokines in obesity-related inflammatory diseases Mediators Inflamm 2010 2010 802078
6. S. Barth, P. Klein, T. Horbach, J. Dotsch, M. Rauh, and W. Rascher Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters Obes Facts 3 August (4) 2010 245 251
7. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat Med 7 August (8) 2001 947 953
8. J. Berndt, N. Kloting, S. Kralisch, P. Kovacs, M. Fasshauer, and M.R. Schon Plasma visfatin concentrations and fat depot-specific mRNA expression in humans Diabetes 54 October (10) 2005 2911 2916
9. D. Boey, L. Heilbronn, A. Sainsbury, R. Laybutt, A. Kriketos, and H. Herzog Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes Neuropeptides 40 October (5) 2006 317 324
10. R.C. Cai, L. Wei, J.Z. Di, H.Y. Yu, Y.Q. Bao, and W.P. Jia Expression of omentin in adipose tissues in obese and type 2 diabetic patients Zhonghua Yi Xue Za Zhi 89 February (6) 2009 381 384
11. K. Chandarana, R. Batterham, and Y.Y. Peptide Curr Opin Endocrinol Diabetes Obes 15 February (1) 2008 65 72
12. S. Chatree, M. Churintaraphan, N.C. Nway, and M.D. Chantacha Sitticharoon Expression of Y2R mRNA expression in subcutaneous and visceral adipose tissues compared between normal weight and obese female subjects 2013
13. J. Chen, B. Tan, E. Karteris, S. Zervou, J. Digby, and E.W. Hillhouse Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines Diabetologia 49 June (6) 2006 1292 1302
14. M.P. Chen, F.M. Chung, D.M. Chang, J.C. Tsai, H.F. Huang, and S.J. Shin Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 91 January (1) 2006 295 299
15. S.S. Cohen, M.D. Gammon, L.B. Signorello, K.E. North, E.M. Lange, and J.H. Fowke Serum adiponectin in relation to body mass index and other correlates in black and white women Ann Epidemiol 21 February (2) 2011 86 94
16. C.M. de Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, and J. Pray Omentin plasma levels and gene expression are decreased in obesity Diabetes 56 June (6) 2007 1655 1661
17. G. Derosa, E. Fogari, A. D'Angelo, L. Bianchi, A. Bonaventura, and D. Romano Adipocytokine levels in obese and non-obese subjects: an observational study Inflammation 36 August (4) 2013 914 920
18. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, and K. Kishimoto Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 January (5708) 2005 426 430
19. B.G. Gabrielsson, L.E. Olofsson, A. Sjogren, M. Jernas, A. Elander, and M. Lonn Evaluation of reference genes for studies of gene expression in human adipose tissue Obes Res 13 April (4) 2005 649 652
20. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, and Y. Okamoto Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 June (6) 2000 1595 1599
21. T. Jongwutiwes, S. Lertvikool, S. Leelaphiwat, S. Rattanasiri, R. Jultanmas, and S. Weerakiet Serum visfatin in Asian women with polycystic ovary syndrome Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol 25 August (8) 2009 536 542
22. E. Karra, K. Chandarana, and R.L. Batterham The role of PYY in appetite regulation and obesity 2008
23. A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, and G. Sullivan Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 July (7) 2000 2402 2410
24. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 June (6) 2004 2548 2556
25. A. Korner, A. Garten, M. Bluher, R. Tauscher, J. Kratzsch, and W. Kiess Molecular characteristics of serum visfatin and differential detection by immunoassays J Clin Endocrinol Metab 92 December (12) 2007 4783 4791
26. M.P. Krause, Y. Liu, V. Vu, L. Chan, A. Xu, and M.C. Riddell Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function Am J Physiol Cell Physiol 295 July (1) 2008 C203 C212
27. S.B. Lecke, F. Mattei, D.M. Morsch, and P.M. Spritzer Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome Fertil Steril 95 May (6) 2011 2044 2049
28. A.S. Lihn, J.M. Bruun, G. He, S.B. Pedersen, P.F. Jensen, and B. Richelsen Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects Mol Cell Endocrinol 219 April (1-2) 2004 9 15
29. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun 221 April (2) 1996 286 289
30. P.R. Martin, R.J. Shea, and M.H. Mulks Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence J Bacteriol 183 February (4) 2001 1168 1174
31. Y. Matsuzawa Establishment of a concept of visceral fat syndrome and discovery of adiponectin Proc Jpn Acad Ser B Phys Biol Sci 86 2 2010 131 141
32. M.B. McEntegart, B. Awede, M.C. Petrie, N. Sattar, F.G. Dunn, and N.G. MacFarlane Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur Heart J 28 April (7) 2007 829 835
33. C. Pagano, C. Pilon, M. Olivieri, P. Mason, R. Fabris, and R. Serra Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans J Clin Endocrinol Metab 91 August (8) 2006 3165 3170
34. J.R. Rao, D.J. Keating, C. Chen, and H.C. Parkington Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPARgamma-dependent and PPARgamma-independent mechanisms Diabetes Obes Metab 14 November (11) 2012 983 989
35. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol Cell Biol 14 February (2) 1994 1431 1437
36. P.A. Sarafidis, A.N. Lasaridis, P.M. Nilsson, M.I. Pikilidou, P.C. Stafilas, and A. Kanaki Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes J Hum Hypertens 21 September (9) 2007 709 716
37. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 November (45) 1995 26746 26749
38. S.E. Shoelson, L. Herrero, and A. Naaz Obesity, inflammation, and insulin resistance Gastroenterology 132 May (6) 2007 2169 2180
39. P.J. Simons, P.S. van den Pangaart, J.M. Aerts, and L. Boon Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization J Endocrinol 192 February (2) 2007 289 299
40. X. Terra, T. Auguet, I. Quesada, C. Aguilar, A.M. Luna, and M. Hernandez Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines Clin Endocrinol 77 November (5) 2012 691 698
41. S. Tsuji, J. Uehori, M. Matsumoto, Y. Suzuki, A. Matsuhisa, and K. Toyoshima Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall J Biol Chem 276 June (26) 2001 23456 23463
42. M. Uribe, D. Zamora-Valdes, M. Moreno-Portillo, L. Bermejo-Martinez, R. Pichardo-Bahena, and H.A. Baptista-Gonzalez Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease Ann Hepatol 7 January-March (1) 2008 67 71
43. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, and S. Uchida Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat Med 8 November (11) 2002 1288 1295
44. P. Yan, D. Liu, M. Long, Y. Ren, J. Pang, and R. Li Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus Exp Clin Endocrinol Diabetes 119 April (4) 2011 257 263
45. R.Z. Yang, M.J. Lee, H. Hu, J. Pray, H.B. Wu, and B.C. Hansen Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am J Physiol Endocrinol Metab 290 June (6) 2006 E1253 E1261
46. H. Yokoyama, M. Emoto, S. Fujiwara, K. Motoyama, T. Morioka, and M. Komatsu Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose J Clin Endocrinol Metab 89 March (3) 2004 1481 1484
47. M.J. Yoon, G.Y. Lee, J.J. Chung, Y.H. Ahn, S.H. Hong, and J.B. Kim Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha Diabetes 55 September (9) 2006 2562 2570
48. B. Zahorska-Markiewicz, M. Olszanecka-Glinianowicz, J. Janowska, P. Kocelak, E. Semik-Grabarczyk, and M. Holecki Serum concentration of visfatin in obese women Metabolism 56 August (8) 2007 1131 1134
49. H. Zhou, X. Song, M. Briggs, B. Violand, W. Salsgiver, and E.A. Gulve Adiponectin represses gluconeogenesis independent of insulin in hepatocytes Biochem Biophys Res Commun 338 December (2) 2005 793 799